|
|
|
|
 |
何玉龙博士实验室 |
|
何玉龙
PhD
遗传学,教授,博士生导师
电话
办公室:58641512
实验室:58641522
电子邮件
:
yhe20005@yahoo.com
yulong.he@nicemice.cn
研究兴趣:
血管新生
(angiogenesis) 与淋巴管新生 (lymphangiogenesis)
的分子调控,以及肿瘤转移的分子机制。
代表论文:
-
Tammela T,
He Y(co-first author),
Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K,
Ylä-Herttuala S, Alitalo K. Distinct Architecture of
Lymphatic Vessels Induced by Chimeric Vascular
Endothelial Growth Factor-C/Vascular Endothelial
Growth Factor Heparin-Binding Domain Fusion
Proteins. Circulation Research 2007 May 3; [Epub
ahead of print].
IF: 9.408
-
He Y,
Rajantie I, Pajusola K, Jeltsch M, Holopainen T,
Yla-Herttuala S, Harding T, Jooss K, Takahashi T,
Alitalo K. VEGFR-3 mediated activation of lymphatic
endothelium is crucial for tumor cell entry and
spread via lymphatic vessels. Cancer Res 65:4739-46(2005).
IF: 8.649
-
He Y,
Rajantie I,
Ilmonen M, Makinen T,
Karkkainen MJ, Haiko P, Salven P, Alitalo K.
Preexisting
lymphatic endothelium but not endothelial progenitor
cells are essential for tumor lymphangiogenesis and
lymphatic metastasis . Cancer Res
64:3737-40
(2004).
IF: 8.649
-
He Y,
Karpanen T and Alitalo K. Role of lymphangiogenic
factors in lymphatic tumor metastasis.
Biochim Biophys Acta
1654:3-12
(2004). IF:
8.395
-
He Y,
Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S,
Takahashi T, Alitalo K. Suppression of tumor
lymphangiogenesis and lymph node metastasis by
blocking vascular endothelial growth factor receptor
3 signaling. J Natl Cancer Inst 94:785-7
(2002). IF: 13.844
-
He Y,
Smith SK, Day KA, Clark D, Licence DR, Charnock-Jones
DS. Alternative splicing of vascular endothelial
growth factor (VEGF)-R1 (FLT-1) pre-mRNA is
important for the regulation of VEGF activity.
Mol Endocrinol 13:537-545 (1999).
IF: 5.708
实验室成员:
技术员:
曹燕兰
研究生:
焦吉祥、周飞、王博、张禄卿、黄惠莲
请进入何玉龙博士个人主页
请进入实验室主页
|
|
|
|
|